Search clinical trials for: Dialysate magnesium formulation of 1.5 mEq/L (0.75 mmol/L).
Total 13 results
-
Lawson Health Research InstituteCanadian Institutes of Health Research (CIHR); ICESActive, not recruitingKidney Diseases | Hemodialysis | End-Stage Kidney DiseaseCanada
-
Iain BressendorffCompletedEndstage Renal DiseaseDenmark
-
University Hospital, MontpellierRecruitingAcute Kidney Injury | Renal Replacement TherapyFrance
-
Soroka University Medical CenterBnai Zion Medical Center; Rivka Ziv Medical CenterCompletedHemodialysis PatientsIsrael
-
Iain BressendorffNot yet recruitingSecondary Hyperparathyroidism | End-stage Kidney Disease
-
Rigshospitalet, DenmarkTrygFonden, DenmarkCompletedAnemia | Arthroplasty | Hip | ReplacementDenmark
-
Sun Yat-sen UniversityCompletedHyperparathyroidism | HypercalcemiaChina
-
Ufuk UniversityRecruiting
-
Teva Neuroscience, Inc.Completed
-
Hospital Clínico Universitario de ValenciaRecruitingHip Fractures | Hemodynamic StabilitySpain
-
Mansoura UniversityActive, not recruitingVaricose Veins | Venous Insufficiency | Venous Leg Ulcer | Venous RefluxEgypt
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedMetastatic Pancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic CancerUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States